About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACRX - AcelRx Pharmaceutica...| Previous Close | $1.03 | Open | $1.03 |
| Volume | 1.93M | Market Cap | 122.68M |
| Yield | Last Dividend |
| AcelRx's Dsuvia Shows Reduction In Posto... | 05/13/21 |
| AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) has announced a poster presentation at the Annual Regional Anesthesiology and Acute Pain Medicine Meeting r... | |
| AcelRx To Test Dsuvia In Patients On Bup... | 04/08/21 |
| AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) has announced an investigator-initiated study to assess the perioperative use of Dsuvia (sufentanil subling... | |
| AcelRx Announces Presentation and Firesi... | 03/22/21 |
| REDWOOD CITY, Calif., March 22, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused... | |
| AcelRx Pharmaceuticals (NASDAQ:ACRX) Iss... | 03/16/21 |
| AcelRx Pharmaceuticals (NASDAQ:ACRX) issued its quarterly earnings data on Sunday. The specialty pharmaceutical company reported ($0.10) earnings per ... | |
| AcelRx Pharmaceuticals Will stock surge ... | 03/15/21 |
| AcelRx Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??... | |
| AcelRx Pharmaceuticals Reports Fourth Qu... | 03/15/21 |
| REDWOOD CITY, Calif., March 15, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused... | |
| AcelRx Announces an Investigator-Initiat... | 02/17/21 |
| REDWOOD CITY, Calif., Feb. 17, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| STAT+: FDA warns AcelRx of misleading ad... | 02/16/21 |
| The FDA warned that messaging from AcelRx Pharmaceuticals failed to convey ???potentially life-threatening risks" associated with Dsuvia. | |
| AcelRx Pharmaceuticals : Announces Prici... | 01/20/21 |
| REDWOOD CITY, Calif., Jan. 20, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and c... | |
| AcelRx Announces Pricing of $27.5 Millio... | 01/20/21 |
| REDWOOD CITY, Calif., Jan. 20, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused o... | |
| AcelRx Announces Underwritten Public Off... | 01/19/21 |
| REDWOOD CITY, Calif., Jan. 19, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused o... | |
| AcelRx Announces an Investigator-Initiat... | 01/19/21 |
| REDWOOD CITY, Calif., Jan. 19, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| Are You Following Analysts On These Penn... | 01/15/21 |
| This year has gotten off to a strong start already. Many stocks, including penny stocks , are reaching new 52-week and all-time highs. Meanwhile, the ... | |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| AcelRx Pharmaceuticals Announces Publica... | 12/10/20 |
| REDWOOD CITY, Calif., Dec. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the dev... | |
| AcelRx Pharmaceuticals Announces Partner... | 12/04/20 |
| REDWOOD CITY, Calif., Dec. 4, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the deve... | |
| AcelRx Pharmaceuticals Announces Comment... | 11/18/20 |
| REDWOOD CITY, Calif., Nov. 18, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the dev... | |
| AcelRx Pharmaceuticals Reports Third Qua... | 11/05/20 |
| REDWOOD CITY, Calif., Nov. 5, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused o... | |
| AcelRx to Host Third Quarter 2020 Financ... | 10/29/20 |
| REDWOOD CITY, Calif., Oct. 29, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced t... | |
| AcelRx Pharmaceuticals (NASDAQ:ACRX) Tra... | 10/22/20 |
| Shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) were up 9.5% during mid-day trading on Thursday . The stock traded as high as $1.90 and last trad... | |
| Pain Management- New Discoveries And Tre... | 10/01/20 |
| The research report on Pain Management Market provides a comprehensive analysis of the market status and development trend, including types, applicati... | |
| AcelRx to Host Virtual KOL Event on Peri... | 09/29/20 |
| REDWOOD CITY, Calif., Sept. 29, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused... | |
| AcelRx awarded ~$3.6M contract for DSUVI... | 09/22/20 |
| AcelRx Pharmaceuticals (ACRX +1.9%) has been awarded an initial contract of up to ~$3.6M for the purchase of DSUVIA to support a study to aid the deve... | |
| AcelRx Announces DSUVIA?? Added to the U... | 09/14/20 |
| REDWOOD CITY, Calif., Sept. 14, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused... | |
| AcelRx Announces an Investigator-Initiat... | 08/24/20 |
| REDWOOD CITY, Calif., Aug. 24, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| AcelRx Pharmaceuticals Reports Second Qu... | 08/10/20 |
| REDWOOD CITY, Calif., Aug. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused ... | |
| AcelRx to Host Second Quarter 2020 Finan... | 08/03/20 |
| REDWOOD CITY, Calif., Aug. 3, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced th... | |
| AcelRx inks deal with Zimmer Biomet to d... | 07/23/20 |
| Zimmer Biomet's (NYSE:ZBH) Dental division has agreed to distribute AcelRx Pharmaceuticals' (NASDAQ:ACRX) Dsuvia (sufentanil sublingual tablet) within... | |
| AcelRx Pharmaceuticals : Announces Exclu... | 07/23/20 |
| REDWOOD CITY, Calif., July 23, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced an agreement to... | |
| AcelRx Announces $10 Million Common Stoc... | 07/23/20 |
| REDWOOD CITY, Calif., July 23, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) (AcelRx), a specialty pharmaceutical company focused on... | |
| Date | 2021-03-15 (AMC) | Est. (EPS/Rev.) | ($0.10)/ 1.73M |
| Actual (EPS/Rev.) | $-0.10/ $738.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Option Superstars | James Catzen | 72.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 70.00 % | Follow |
| Biotech picks | mr jackson | 50.00 % | Follow |
| Biotech | Sajjadul Kibria | 50.00 % | Follow |
| R R Investments | Roland Van Rij | 44.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
